お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
市場調査レポート
商品コード
649275

世界の経肺ドラッグデリバリーシステム市場:市場シナリオ、市場規模、動向、予測

Global Pulmonary Drug Delivery Systems Market by Product - Global Scenario, Market Size, Outlook, Trend and Forecast, 2016-2025

出版日: | 発行: Variant Market Research LLP | ページ情報: 英文 101 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=106.41円
世界の経肺ドラッグデリバリーシステム市場:市場シナリオ、市場規模、動向、予測
出版日: 2018年06月03日
発行: Variant Market Research LLP
ページ情報: 英文 101 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の経肺ドラッグデリバリーシステム市場を調査し、市場の概要、製品タイプ・用途・流通チャネル・地域別の市場動向、市場規模の推移と予測、市場シェア、市場促進・阻害要因ならびに市場機会の分析、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 前年比成長率の推移と見通し

第3章 市場アウトライン

  • 市場の傾向、動向、見通し、着眼点
  • 市場シェアの分析:企業の競合シナリオ
  • 市場力学
    • 促進要因
    • 阻害要因
    • 市場機会

第4章 世界の経肺ドラッグデリバリーシステム市場:製品タイプ別

  • 市場概要
  • ドライパウダー吸入器(DPI)
    • 単回投与型
    • 多回投与型
  • 定量吸入器(MDI)
    • 手動式吸入器
    • 呼気感応型吸入器
  • ネブライザー
    • ジェット式ネブライザー
    • 超音波式ネブライザー
    • メッシュ式ネブライザー

第5章 世界の経肺ドラッグデリバリーシステム市場:用途別

  • 市場概要
  • 喘息
  • 慢性閉塞性肺疾患
  • 嚢胞性繊維症
  • その他

第6章 世界の経肺ドラッグデリバリーシステム市場:流通チャネル別

  • 市場概要
  • 小売薬局
  • 院内薬局
  • eコマース

第7章 世界の経肺ドラッグデリバリーシステム市場:地域別

  • 市場概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • その他
  • アジア太平洋
    • インド
    • 中国
    • 日本
    • 韓国
    • その他
  • その他の地域
    • 南米
    • 中東
    • アフリカ

第8章 企業プロファイル

  • AstraZeneca plc
  • Boehringer Ingelheim Gmbh
  • GlaxoSmithKline plc
  • Novartis AG
  • Koninklijke Philips N.V
  • 3M Company
  • Actelion Pharmaceuticals Ltd
  • Clement Clarke International
  • Briggs Healthcare
  • Aerogen
目次

Global pulmonary drug delivery system market is estimated to reach $54.9 Billion by 2025 with CAGR of 6.2% between 2017 and 2025. Pulmonary drug delivery system is used to target diseases in the airways by delivering locally acting drugs directly to their site of action. Pulmonary route of drug delivery offer advantages such as small amount of drug, less adverse reaction and rapid onset of action. Increasing prevalence of chronic respiratory diseases like asthma, bronchitis is expected to grow the market of Pulmonary Drug Delivery Systems.

The major factors that fuel the market are; rising air pollution, increase in smoking, tuberculosis, chronic obstructive pulmonary disease, increasing demand for non-invasive methods, technological advancements such as smart inhaler, increasing geriatrics population. However, regulatory approvals and patent expiration of drugs may hamper the growth of global pulmonary drug delivery market. Moreover, rise in use of online marketing creates further opportunities for the market to sustain in the upcoming years.

The global pulmonary drug delivery systems market is segmented on the basis of product, application, and geography. On the basis of product, it is divided into metered dose inhalers (breath-actuated pressurized inhaler and manually-actuated pressurized inhaler), nebulizers (jet nebulizers, ultrasonic nebulizers, and vibrating mesh nebulizers), and dry powder inhalers (single dose inhalers and multi-dose inhalers). On the basis of distributor segment it is bifurcated into retail pharmacies, hospital pharmacies, and e-commerce. On the basis of application, the market is segmented into asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD), and others.

By geography, the global pulmonary drug delivery system market is segmented into North America, Europe, Asia-Pacific, and Rest of the world (RoW). The U.S., Canada, and Mexico are covered under North America wherein Europe covers UK, Germany, France, Italy, and others. Asia-Pacific covers China, India, Japan, South Korea, and others. Rest of the World covers South America, Middle East and Africa.

Key players in pulmonary drug delivery system market include: AstraZeneca plc, Boehringer Ingelheim Gmbh, GlaxoSmithKline plc, Novartis AG, Koninklijke Philips N.V., 3M Company, Actelion Pharmaceuticals Ltd, Clement Clarke International, Briggs Healthcare, and Aerogen.

The key takeaways from the report

  • The report will provide a detailed analysis of Global Pulmonary Drug Delivery System Market with respect to major segments such as product, application, distribution channel, and geography
  • The report will include the qualitative and quantitative analysis with market estimation over 2016-2025 and compound annual growth rate (CAGR) between 2017 and 2025
  • Comprehensive analysis of market dynamics including factors and opportunities will be provided in the report
  • An exhaustive regional analysis of Global Pulmonary Drug Delivery System Market from 2016 to 2025 has been included in the report
  • Profile of the key players in the Global Pulmonary Drug Delivery System Market will be provided, which include key financials, product & services, new developments and business strategies

Scope of the Global Pulmonary Drug Delivery System Market

Type Segments

  • Dry Powder Inhalers
    • Single dose inhaler
    • Multi dose inhaler
  • Metered dose inhalers
    • Manually-Actuated Pressurized Inhaler
    • Breath-Actuated Pressurized Inhaler

Application Segments

  • Asthma
  • Chronic obstructive pulmonary disease (COPD)
  • Cystic Fibrosis
  • Others

Distribution Channel Segments

  • Retail Pharmacies
  • Hospital Pharmacies
  • E-Commerce

Geographical Segments

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • RoW
    • South America
    • Middle East
    • Africa

Table of Contents

Chapter 1 Prefix

  • 1.1 Market Scope
  • 1.2 Report Description
  • 1.3 Research Methodology
    • 1.3.1 Primary Research
    • 1.3.2 Secondary Research
    • 1.3.3 In-house Data Modeling

Chapter 2 Executive Summary

  • 2.1 Global Pulmonary Drug Delivery System Market Year-on-Year Growth, 2017 - 2025 (%)

Chapter 3 Market Outline

  • 3.1 Market Inclination, Trend, Outlook and Viewpoint
  • 3.2 Market Share Analysis: Company's Competitive Scenario
  • 3.3 Market Dynamics
    • 3.3.1 Drivers
      • 3.3.1.1 Impact Analysis
    • 3.3.2 Restraints
      • 3.3.2.1 Impact Analysis
    • 3.3.3 Opportunities

Chapter 4 Global Pulmonary Drug Delivery System Market by Product: Market Size and Forecast, 2016 - 2025

  • 4.1 Overview
  • 4.2 Dry Powder Inhalers
    • 4.2.1 Current Trend and Analysis
    • 4.2.2 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 4.2.3 Market Size and Forecast by Region, 2016 - 2025 ($ Billion)
    • 4.2.4 Single Dose Inhalers
      • 4.2.4.1 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 4.2.5 Multi Dose Inhalers
      • 4.2.5.1 Market Size and Forecast, 2016 - 2025 ($ Billion)
  • 4.3 Metered Dose Inhalers
    • 4.3.1 Current Trend and Analysis
    • 4.3.2 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 4.3.3 Market Size and Forecast by Region, 2016 - 2025 ($ Billion)
    • 4.3.4 Manually Actuated Pressurized Inhaler
      • 4.3.4.1 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 4.3.5 Breath Actuated Pressurized Inhaler
      • 4.3.5.1 Market Size and Forecast, 2016 - 2025 ($ Billion)
  • 4.4 Nebulizers
    • 4.4.1 Current Trend and Analysis
    • 4.4.2 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 4.4.3 Market Size and Forecast by Region, 2016 - 2025 ($ Billion)
    • 4.4.4 Jet Nebulizers
      • 4.4.4.1 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 4.4.5 Ultrasonic Wave Nebulizers
      • 4.4.5.1 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 4.4.6 Vibrating Mesh Nebulizers
      • 4.4.6.1 Market Size and Forecast, 2016 - 2025 ($ Billion)

Chapter 5 Global Pulmonary Drug Delivery System Market by Application: Market Size and Forecast, 2016 - 2025

  • 5.1 Overview
  • 5.2 Asthma
    • 5.2.1 Current Trend and Analysis
    • 5.2.2 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 5.2.3 Market Size and Forecast by Region, 2016 - 2025 ($ Billion)
  • 5.3 Chronic Obstructive Pulmonary Disease
    • 5.3.1 Current Trend and Analysis
    • 5.3.2 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 5.3.3 Market Size and Forecast by Region, 2016 - 2025 ($ Billion)
  • 5.4 Cystic Fibrosis
    • 5.4.1 Current Trend and Analysis
    • 5.4.2 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 5.4.3 Market Size and Forecast by Region, 2016 - 2025 ($ Billion)
  • 5.5 Others
    • 5.5.1 Current Trend and Analysis
    • 5.5.2 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 5.5.3 Market Size and Forecast by Region, 2016 - 2025 ($ Billion)

Chapter 6 Global Pulmonary Drug Delivery System Market by Distribution Channel: Market Size and Forecast, 2016 - 2025

  • 6.1 Overview
  • 6.2 Retail Pharmacies
    • 6.2.1 Current Trend and Analysis
    • 6.2.2 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 6.2.3 Market Size and Forecast by Region, 2016 - 2025 ($ Billion)
  • 6.3 Hospital Pharmacies
    • 6.3.1 Current Trend and Analysis
    • 6.3.2 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 6.3.3 Market Size and Forecast by Region, 2016 - 2025 ($ Billion)
  • 6.4 E-Commerce
    • 6.4.1 Current Trend and Analysis
    • 6.4.2 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 6.4.3 Market Size and Forecast by Region, 2016 - 2025 ($ Billion)

Chapter 7 Global Pulmonary Drug Delivery System Market by Geography: Market Size and Forecast, 2016 - 2025

  • 7.1 Overview
    • 7.1.1 Global Pulmonary Drug Delivery System Market Year-on-Year Growth, by regions 2017 - 2025 (%)
  • 7.2 North America
    • 7.2.1 Current Trend and Analysis
    • 7.2.2 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 7.2.3 U.S.
      • 7.2.3.1 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 7.2.4 Canada
      • 7.2.4.1 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 7.2.5 Mexico
      • 7.2.5.1 Market Size and Forecast, 2016 - 2025 ($ Billion)
  • 7.3 Europe
    • 7.3.1 Current Trend and Analysis
    • 7.3.2 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 7.3.3 UK
      • 7.3.3.1 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 7.3.4 Germany
      • 7.3.4.1 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 7.3.5 France
      • 7.3.5.1 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 7.3.6 Italy
      • 7.3.6.1 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 7.3.7 Rest of Europe
      • 7.3.7.1 Market Size and Forecast, 2016 - 2025 ($ Billion)
  • 7.4 Asia-Pacific
    • 7.4.1 Current Trend and Analysis
    • 7.4.2 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 7.4.3 India
      • 7.4.3.1 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 7.4.4 China
      • 7.4.4.1 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 7.4.5 Japan
      • 7.4.5.1 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 7.4.6 South Korea
      • 7.4.6.1 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 7.4.7 Rest of Asia-Pacific
      • 7.4.7.1 Market Size and Forecast, 2016 - 2025 ($ Billion)
  • 7.5 RoW
    • 7.5.1 Current Trend and Analysis
    • 7.5.2 Market Size and Forecast
    • 7.5.3 South America
      • 7.5.3.1 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 7.5.4 Middle East
      • 7.5.4.1 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 7.5.5 Africa
      • 7.5.5.1 Market Size and Forecast, 2016 - 2025 ($ Billion)

Chapter 8 Company Profiles

  • 8.1 AstraZeneca plc
  • 8.2 Boehringer Ingelheim Gmbh
  • 8.3 GlaxoSmithKline plc
  • 8.4 Novartis AG
  • 8.5 Koninklijke Philips N.V
  • 8.6 3M Company
  • 8.7 Actelion Pharmaceuticals Ltd
  • 8.8 Clement Clarke International
  • 8.9 Briggs Healthcare
  • 8.10 Aerogen
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.